Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › FL › Jacksonville › NPI 1134117575
Hospital

ST Vincents Medical Center INC

ST Vincents Medical Center INC was paid $12.67M by Medicaid between Jan 2018 and Dec 2024, across 238 billing codes. Its largest line is 99285, emergency room visit (most serious) — 20% of everything it billed.

33Billing provider infoST VINCENTS MEDICAL CENTER INC
JACKSONVILLE, FL 32204
33aNPI1134117575assigned 10/10/2005
28Total paid$12.67M
24GClaims483,555
24DCodes billed238
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Florida

Rank by total paid#40 of 163
Median peer was paid$4.77M
This provider vs. median2.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201856,060$490K
2019106,937$2.50M
202087,419$2.19M
2021102,986$2.93M
202298,537$3.21M
202327,418$1.09M
2024incomplete4,198$264K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 20% 27,742 23,108 $2.57M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 9.0% 12,465 11,382 $1.15M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 7.2% 12,013 10,639 $910K
36415 Collection of venous blood by venipuncture 5.3% 24,611 17,294 $677K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 4.8% 4,264 3,721 $605K
99282 Emergency department visit for the evaluation and management, low to moderate severity 3.6% 5,986 5,495 $454K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 2.8% 8,914 7,983 $349K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 2.6% 990 875 $334K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 2.5% 6,159 5,105 $316K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 2.3% 1,460 1,248 $291K
95810 Polysomnography; sleep staging with 4 or more additional parameters 2.2% 754 705 $281K
80053 Comprehensive metabolic panel 2.1% 19,243 15,456 $261K
226 more codes
70450 Computed tomography, head or brain; without contrast material 1.6% 4,993 $209K
59025 Fetal non-stress test 1.5% 2,123 $193K
96361 Intravenous infusion, hydration; each additional hour 1.5% 2,929 $191K
80048 Basic metabolic panel (calcium, ionized) 1.5% 9,823 $187K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.4% 3,964 $178K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 1.4% 2,326 $178K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.4% 3,563 $176K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 1.0% 2,625 $132K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 1,434 $118K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,609 $107K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 12,200 $92K
71046 Radiologic examination, chest; 2 views <1% 4,581 $90K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,553 $85K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 1,690 $82K
G0378 Hospital observation service, per hour <1% 9,542 $82K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 5,688 $73K
A9585 Injection, gadobutrol, 0.1 ml <1% 624 $73K
41899 Unlisted procedure, dentoalveolar structures <1% 81 $73K
77067 Screening mammography, bilateral, including computer-aided detection <1% 2,803 $66K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 923 $65K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,396 $64K
71250 <1% 1,674 $60K
76536 <1% 819 $59K
76642 <1% 1,148 $59K
71275 Computed tomographic angiography, chest, with contrast material <1% 1,201 $58K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 811 $53K
82962 <1% 8,026 $52K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 2,647 $52K
76830 Ultrasound, transvaginal <1% 1,869 $50K
86901 <1% 2,354 $49K
93017 <1% 1,611 $48K
77066 Tomosynthesis, mammo <1% 889 $46K
A9270 Non-covered item or service <1% 12,079 $44K
72100 <1% 1,139 $42K
93970 <1% 1,047 $39K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 4,341 $38K
95811 <1% 128 $36K
93971 <1% 1,324 $35K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 286 $34K
86850 <1% 1,657 $33K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 28,403 $32K
97162 <1% 929 $32K
76770 <1% 424 $32K
73562 <1% 1,729 $30K
72040 <1% 846 $30K
J7030 Infusion, normal saline solution , 1000 cc <1% 10,279 $29K
73030 <1% 1,293 $28K
70551 Magnetic resonance imaging, brain; without contrast material <1% 359 $24K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 272 $24K
71045 Radiologic examination, chest; single view <1% 12,186 $24K
81001 <1% 8,364 $23K
87210 <1% 1,273 $23K
73630 <1% 1,512 $22K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 561 $22K
81002 <1% 920 $21K
77080 <1% 575 $20K
73610 <1% 856 $20K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 14,976 $19K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 2,549 $19K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 3,687 $18K
84112 <1% 120 $18K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,106 $17K
73130 <1% 733 $15K
96375 Therapeutic injection; each additional sequential IV push <1% 7,272 $14K
76801 <1% 1,129 $14K
77063 Screening digital breast tomosynthesis, bilateral <1% 1,225 $14K
87400 <1% 1,520 $13K
87086 Culture, bacterial; quantitative colony count, urine <1% 2,405 $13K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 337 $13K
81003 <1% 3,858 $13K
87081 <1% 463 $12K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 484 $12K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 1,124 $12K
86900 <1% 2,079 $11K
84484 <1% 11,758 $11K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 7,459 $11K
99213 Doctor's office visit, returning patient (routine) <1% 161 $11K
J1644 Injection, heparin sodium, per 1000 units <1% 3,836 $11K
81025 <1% 4,324 $10K
73502 <1% 570 $10K
72110 <1% 697 $10K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,359 $10K
82731 <1% 57 $9K
97161 <1% 169 $9K
99152 <1% 619 $9K
87631 <1% 102 $9K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,873 $8K
84703 <1% 4,071 $8K
J1815 Injection, insulin, per 5 units <1% 2,671 $8K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 142 $8K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 154 $8K
84702 <1% 1,701 $7K
77065 Tomosynthesis, mammo <1% 151 $7K
80061 Lipid panel <1% 2,149 $7K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries <1% 16 $7K
G0379 Direct admission of patient for hospital observation care <1% 177 $7K
J7050 Infusion, normal saline solution, 250 cc <1% 2,829 $7K
97163 <1% 130 $7K
96376 <1% 2,764 $7K
85610 <1% 4,675 $7K
J7120 Ringers lactate infusion, up to 1000 cc <1% 3,350 $6K
J0690 Injection, cefazolin sodium, 500 mg <1% 1,505 $6K
87641 <1% 378 $6K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 1,333 $6K
85730 <1% 3,275 $6K
73110 <1% 237 $6K
83036 Hemoglobin; glycosylated (A1C) <1% 2,246 $5K
C1769 Guide wire <1% 290 $5K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 90 $5K
74240 <1% 57 $5K
29581 <1% 47 $5K
74018 <1% 278 $5K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 23 $5K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 105 $5K
83735 <1% 3,539 $5K
72125 Computed tomography, cervical spine; without contrast material <1% 1,329 $5K
99153 Mod sedat endo service >5yrs <1% 307 $4K
83880 <1% 3,157 $4K
J2270 Injection, morphine sulfate, up to 10 mg <1% 3,208 $4K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 1,161 $4K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 229 $4K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 4,668 $3K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 28 $3K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 2,467 $3K
72072 <1% 111 $3K
71271 <1% 39 $3K
J2704 Injection, propofol, 10 mg <1% 1,863 $3K
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals <1% 266 $2K
10060 <1% 12 $2K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 43 $2K
94726 <1% 40 $2K
J0360 Injection, hydralazine hcl, up to 20 mg <1% 561 $2K
J1650 Injection, enoxaparin sodium, 10 mg <1% 741 $2K
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 266 $2K
97116 <1% 127 $2K
70486 <1% 72 $2K
83690 <1% 4,971 $1K
80076 <1% 134 $1K
84443 Thyroid stimulating hormone (TSH) <1% 1,587 $1K
87077 <1% 417 $1K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,392 $1K
J1245 Injection, dipyridamole, per 10 mg <1% 395 $1K
J0153 Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) <1% 286 $1K
J1170 Injection, hydromorphone, up to 4 mg <1% 1,117 $1K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 600 $962.54
94060 <1% 43 $951.51
99214 Doctor's office visit, returning patient (more involved) <1% 13 $886.32
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 605 $884.52
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 446 $836.29
88341 <1% 16 $826.77
78815 Positron emission tomography (PET) for limited area imaging <1% 16 $788.09
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 620 $747.20
J2550 Injection, promethazine hcl, up to 50 mg <1% 813 $712.83
88342 <1% 37 $691.14
93880 <1% 45 $680.97
J3475 Injection, magnesium sulfate, per 500 mg <1% 179 $643.48
85379 <1% 573 $633.97
83605 <1% 3,104 $579.25
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 970 $565.33
73080 <1% 15 $501.31
82565 <1% 232 $480.99
J1750 Injection, iron dextran, 50 mg <1% 16 $393.71
84145 <1% 125 $387.77
87186 <1% 755 $387.16
80329 <1% 688 $343.18
87205 <1% 127 $300.99
87070 <1% 33 $285.62
72131 <1% 26 $283.52
82570 <1% 72 $274.93
87430 <1% 442 $241.94
86140 <1% 410 $222.32
84132 <1% 127 $209.31
80320 <1% 494 $197.49
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 77 $185.27
87040 <1% 822 $162.88
97166 <1% 76 $137.57
73590 <1% 26 $136.99
77062 <1% 90 $125.48
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 191 $124.68
86923 <1% 34 $106.63
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 246 $97.42
87634 <1% 156 $86.93
90715 <1% 29 $84.08
87807 <1% 12 $81.95
74021 <1% 67 $74.10
82803 <1% 19 $40.96
84550 <1% 62 $38.41
93325 <1% 23 $29.02
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 33 $26.50
82077 <1% 371 $24.96
94729 <1% 42 $21.11
82607 <1% 45 $19.21
82247 <1% 15 $18.48
84439 <1% 268 $16.82
82550 <1% 179 $9.66
85027 <1% 148 $7.57
87147 <1% 42 $5.20
82248 <1% 33 $4.64
J3370 Injection, vancomycin hcl, 500 mg <1% 192 $4.54
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 179 $4.15
85014 <1% 45 $3.96
85652 <1% 174 $3.44
85018 <1% 47 $1.98
J2785 Injection, regadenoson, 0.1 mg <1% 44 $0.50
90686 <1% 180 $0.33
G0008 Administration of influenza virus vaccine <1% 172 $0.33
J2060 Injection, lorazepam, 2 mg 0% 239 $0.00
J2765 Injection, metoclopramide hcl, up to 10 mg 0% 285 $0.00
J0330 Injection, succinylcholine chloride, up to 20 mg 0% 290 $0.00
J3480 Injection, potassium chloride, per 2 meq 0% 31 $0.00
J0280 Injection, aminophyllin, up to 250 mg 0% 14 $0.00
99406 0% 25 $0.00
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg 0% 30 $0.00
J1940 Injection, furosemide, up to 20 mg 0% 65 $0.00
83615 0% 89 $0.00
97535 Self-care/home management training, each 15 minutes 0% 39 $0.00
36430 0% 18 $0.00
88300 0% 16 $0.00
84100 0% 67 $0.00
82010 0% 29 $0.00
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 0% 19 $0.00
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 0% 96 $0.00
84156 0% 44 $0.00
A9577 Injection, gadobenate dimeglumine (multihance), per ml 0% 17 $0.00
36600 0% 19 $0.00
77061 0% 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialROMINE, DONNIE (COO SVHC/PRESIDENT SVR)